Phenylalanine enhances innate immune response to clear ceftazidime-resistant Vibrio alginolyticus in Danio rerio.
Animals
Anti-Bacterial Agents
/ pharmacology
Ceftazidime
/ pharmacology
Drug Resistance, Bacterial
/ immunology
Fish Diseases
/ immunology
Immunity, Innate
/ genetics
Microbial Sensitivity Tests
Phenylalanine
/ metabolism
Vibrio Infections
/ immunology
Vibrio alginolyticus
/ drug effects
Zebrafish
/ genetics
Ceftazidime resistance
Innate immune response
Metabolomics
Phenylalanine
Vibrio alginolyticus
Journal
Fish & shellfish immunology
ISSN: 1095-9947
Titre abrégé: Fish Shellfish Immunol
Pays: England
ID NLM: 9505220
Informations de publication
Date de publication:
Jan 2019
Jan 2019
Historique:
received:
30
05
2018
revised:
17
10
2018
accepted:
26
10
2018
pubmed:
6
11
2018
medline:
23
3
2019
entrez:
4
11
2018
Statut:
ppublish
Résumé
Antibiotic-resistant bacteria becomes a major threat to the economy and food safety in aquaculture. Although the antibiotic-dependent strategy is still the mostly adopted option, the development of antibiotic-free approach is urgently needed to ameliorate the severe situation of the global antibiotic resistance. In the present study, we showed that modulating the metabolism of zebrafish, Danio reiro, would enhance D. rerio to clear ceftazidime-resistant Vibrio alginoyticus (Caz-R) in vivo. By generating Caz-R in vitro, we found Caz-R stays longer than ceftazidime-sensitive V. alginoyticus (Caz-S) in D. rerio, where Caz-R induced less potent immune response than that of Caz-S. The differential immune response was associated with different metabolism of the host. Through functional metabolomics, we identified a crucial biomarker, phenylalanine. The abundance of phenylalanine was increased in both of Caz-S and Caz-R infected hosts but the abundance was higher in Caz-S infected group. This specific difference indicated phenylalanine could be a metabolite required to clear Caz-R by the host. Exogenous phenylalanine would enhance the host's ability to remove Caz-R, which was through upregulated production of lysozyme and C3b. Thus, our study demonstrates a novel strategy to boost host's immune response to combat against antibiotic-resistant bacteria.
Identifiants
pubmed: 30389644
pii: S1050-4648(18)30704-6
doi: 10.1016/j.fsi.2018.10.071
pii:
doi:
Substances chimiques
Anti-Bacterial Agents
0
Phenylalanine
47E5O17Y3R
Ceftazidime
9M416Z9QNR
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
912-919Informations de copyright
Copyright © 2018 Elsevier Ltd. All rights reserved.